Who We Are
Jabs Biotech PVT LTD is researching and making medicine which is accessible to all by. We market and manufacturer the high-quality range of medicine at the affordable prices yet our products comply the international standards. Jabs Biotech is driven by the innovation and thus, have excellent R&D facilities expertise. Through our quality product range and business opportunity, we are striving to achieve the leadership in the domestic and international market.
Jabs Biotech Pvt Ltd is India’s leading PCD Pharma Franchise Company based in Patiala. The Company was incorporated in 2012 by the well known and reputed name in the pharmaceutical sector Mr. Harjinder Batheja. Under his guidance Jabs Biotech Pvt Ltd today is considered on among the Top PCD Pharma Franchise companies in India. Our customer-centric business strategies along with the quality products make Jabs Biotech Pvt Ltd an ideal company for business in pharmaceutical.
From the initial stage of Jab Biotech Pvt Ltd, patient’s wellness and life was our priority. We are focused on developing acquire and commercialize new treatment options for patients with challenging conditions that no one else is tackling.
The strengths of Jabs Biotec
We are the leading manufacturer of the niche and complex medicine in the Pharmaceutical industry. Our company meets the expectation and needs of patients and business partner.
Here are our strengths which make us the best name for PCD Pharma Franchise business in India:
Research: The company has its strength in research. We have an excellent team of researchers who are exceptionally well in delivering innovative products through effective API’s.
Integration: Jabs Biotech is integrated through the value supply chain. All the manufacturing take place following right procedure and process. This is beneficial for us in terms of terms of cost, quality, and logistics.
Product Category: We cover the wide range of product category and ensure to deliver them on time. We provide the products covering various categories like oncology, CNS, gastrointestinal, migraine and anti-depressant segments, each of which is growing in size and scope.
Our mission is to conduct effective advocacy for public policies that encourage discovery of important new medicines for patients by pharmaceutical and biotechnology research companies. To accomplish this mission, Jabs is dedicated to achieving these goals in the states and the world:
Broad patient access to safe and effective medicines through a free market, without price controls;
Strong intellectual property incentives;
And transparent, effective regulation and a free flow of information to patients.